# US 10,870,887 B2 · Mutations in SPTLC2 gene associated with sensory neuropathy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 10,870,887 B2
- Document ID: US10870887B2
- Status: Granted
- Kind: B2
- Application number: 15/814,766
- Filed: 2017-11-16
- Published: 2018-06-07
- Granted: 2020-12-22
- Earliest claimed: 2010-09-17
- Assignees: Vib Vzw; Universiteit Antwerpen; University of Zurich; Medical University of Graz
- Applicants: Vib Vzw; Universiteit Antwerpen; University of Zurich; Medical University of Graz
- Inventors: Annelies Rotthier; Vincent Timmerman; Michaela Auer-Grumbach; Thorsten Hornemann
- Web page: https://patentgrep.com/patent/US10870887B2

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Described are methods and kits for identifying a subject at risk of, or having, a sensory neuropathy related disease, such as sensory neuropathies. In particular, the disclosure is based on the determination of mutations in the SPTLC2 gene causing sensory neuropathies.

## Claims

### Claim 1

A nucleic acid probe comprising a fragment of a SPTLC2 sequence or the complementary sequence thereof, wherein the SPTLC2 sequence has the sequence of SEQ ID NO: 2, and comprises a mutation in at least one nucleotide position corresponding to a position selected from the group consisting of 1145, 1075, and 1510 relative to the ATG start codon beginning at position 189 of SEQ ID NO:2; and
wherein the nucleic acid probe hybridizes to the variant SPTLC2 sequence but not to the wild type SPTLC2 sequence, wherein the nucleic acid probe is 25 to 100 nucleotides in length, and wherein the nucleic acid probe is detectably labeled with a fluorescent, chemiluminescent, enzymatic, radioactive, or chemical label.

### Claim 2 (depends on 1)

The nucleic acid probe of claim 1, wherein the mutation is selected from the group consisting of c.1075G>A, c.1145G>T, and c.1510 A>T of the SPTLC2 sequence.

### Claim 3 (depends on 1)

The nucleic acid probe of claim 1, wherein the nucleic acid probe is directly labeled with a fluorescent label.

### Claim 4 (depends on 1)

The nucleic acid probe of claim 1, wherein the probe is 25-30 nucleotides long.

### Claim 5 (depends on 1)

The nucleic acid probe of claim 1, wherein the probe is 25-40 nucleotides long.

### Claim 6 (depends on 1)

A kit for detecting a mutation in SPTLC2 nucleic acid, comprising the nucleic acid probe of claim 1.